Whitney Smith represents clients in mergers and acquisitions, joint ventures, debt and equity investments, and other business transactions. He advises Fortune 500 companies as well as middle-market and emerging growth companies in a broad range of industries, including healthcare, technology, financial services, media and logistics, with a particular focus on the pharmaceuticals industry.
In addition to corporate transactions, Mr. Smith advises public companies and their Boards of Directors in connection with compliance with SEC reporting and corporate governance matters and activist investor situations. Mr. Smith’s transactions are often cross-boarder in nature, including a number of acquisitions in India, and are middle-market focused with transaction values in the $30 million to $1 billion range.
